Skip to content

Connexin 40 polymorphism and protein expression in the right atrial appendix in patients without atrial fibrillation.

Connexin 40 polymorphism and protein expression in the right atrial appendix in patients without atrial fibrillation. - Cx40 gene polymorphism and in vivo protein expression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31871
Enrollment
240
Registered
2008-09-16
Start date
2008-10-16
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients planned for cardiac surgery. Age *18 years. Written informed consent.

Exclusion criteria

Exclusion criteria: Permanent AF. Mitral valve abnormalities (stenosis / regurgitation). Left atrial size >50 mm (transthoracic echocadardiography).

Design outcomes

Primary

MeasureTime frame
Indentifying the relation between Cx40 polymorphism and in vivo protein expression in patients without a history of AF.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)